CBCFF(CBCFF)
CBCFF
No analyst ratings available
No analyst price targets available for CBCFF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $369.43B | $385.16B | $397.03B | $405.05B | $415.18B |
| Low | $364.65B | $367.33B | $385.16B | $392.94B | $402.77B |
| High | $372.85B | $396.86B | $404.97B | $413.15B | $423.48B |
| EBITDA Avg | $47.21B | $52.33B | $55.96B | $63.39B | $66.55B |
| Low | $46.16B | $51.18B | $54.74B | $61.95B | $65.06B |
| High | $47.91B | $53.10B | $56.77B | $64.34B | $67.55B |
| EBIT Avg | $27.33B | $30.05B | $31.56B | $37.16B | $38.70B |
| Low | $26.28B | $28.90B | $30.35B | $35.73B | $37.21B |
| High | $28.03B | $30.82B | $32.37B | $38.12B | $39.70B |
| Net Income Avg | $18.13B | $19.96B | $20.97B | $24.73B | $25.76B |
| Low | $17.42B | $19.18B | $20.16B | $23.77B | $24.76B |
| High | $18.60B | $20.48B | $21.52B | $25.37B | $26.43B |
| EPS Avg | $146.43 | $161.20 | $169.39 | $199.77 | $208.09 |
| Low | $140.74 | $154.94 | $162.81 | $192.01 | $200.01 |
| High | $150.24 | $165.39 | $173.79 | $204.96 | $213.50 |
| Analysts (Rev / EPS) | 5 / 1 | 6 / 1 | 4 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $91.07B | $99.09B | $93.59B |
| Low | $90.12B | $97.92B | $92.55B |
| High | $92.15B | $100.25B | $94.69B |
| EBITDA Avg | $9.40B | $14.19B | $11.34B |
| Low | $9.33B | $14.06B | $11.25B |
| High | $9.47B | $14.33B | $11.44B |
| EBIT Avg | $4.74B | $9.35B | $6.36B |
| Low | $4.67B | $9.22B | $6.27B |
| High | $4.81B | $9.49B | $6.46B |
| Net Income Avg | $3.11B | $6.21B | $4.20B |
| Low | $3.06B | $6.12B | $4.14B |
| High | $3.16B | $6.30B | $4.26B |
| EPS Avg | $25.56 | $51.04 | $34.52 |
| Low | $25.19 | $50.30 | $34.02 |
| High | $25.95 | $51.82 | $35.05 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 |